Action: Ask Your Members of Congress to Support the Cancer Drug Parity Act!

For many people living with cancer, oral chemotherapy is an option that allows for more convenient treatment than intravenous (IV) medicines. However, the way oral drugs are covered by insurance often means much higher copays, making them unaffordable.

The Cancer Drug Parity Act is a bipartisan bill that was recently reintroduced in the Senate. This legislation would prevent insurers from requiring higher copays for oral cancer drugs compared to IV therapies.

LUNGevity strongly supports this legislation as a way to improve the affordability of treatment options for patients, and we encourage you to write your senators today and ask them to support the Cancer Drug Parity Act.